{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:08:54Z","timestamp":1793902134284,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["22\/12027-0"],"award-info":[{"award-number":["22\/12027-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2024\/04275\\u20139"],"award-info":[{"award-number":["2024\/04275\\u20139"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.drudis.2025.104553","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:55:19Z","timestamp":1763657719000},"page":"104553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["FPR2 at the crossroads of inflammation and repair in the eye"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-1853","authenticated-orcid":false,"given":"Rafael Andr\u00e9","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2017-1971","authenticated-orcid":false,"given":"Anna","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1347-4244","authenticated-orcid":false,"given":"Kendra","family":"Jones-Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-2055","authenticated-orcid":false,"given":"Shama","family":"Parween","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-8945","authenticated-orcid":false,"given":"Ana Paula","family":"Girol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3943-977X","authenticated-orcid":false,"given":"Sandra H.P.","family":"Farsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6979-4126","authenticated-orcid":false,"given":"Cristiane D.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4545-8181","authenticated-orcid":false,"given":"M.","family":"Natalia Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104553_b0005","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41433-024-03512-4","article-title":"Evolution of the ocular immune system","volume":"39","author":"Forrester","year":"2025","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2025.104553_b0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/medicina61020177","article-title":"Lipoxin A4 (LXA4) as a potential drug for diabetic retinopathy","volume":"61","author":"Das","year":"2025","journal-title":"Medicina"},{"key":"10.1016\/j.drudis.2025.104553_b0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molimm.2023.04.007","article-title":"Protective effects of resolvin D1 in Pseudomonas aeruginosa keratitis","volume":"158","author":"Wu","year":"2023","journal-title":"Mol Immunol"},{"key":"10.1016\/j.drudis.2025.104553_b0020","first-page":"242","article-title":"Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: possible involvement of NLRP3 inflammasome and NF-\u03baB signaling pathway","volume":"23","author":"Yin","year":"2017","journal-title":"Mol Vis"},{"key":"10.1016\/j.drudis.2025.104553_b0025","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/molecules22030455","article-title":"The formyl peptide receptors: diversity of ligands and mechanism for recognition","volume":"22","author":"He","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104553_b0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","article-title":"Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses","volume":"17","author":"Migeotte","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.drudis.2025.104553_b0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/bcpt.12903","article-title":"Formyl peptide receptors in mice and men: similarities and differences in recognition of conventional ligands and modulating lipopeptides","volume":"122","author":"Winther","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.drudis.2025.104553_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115989","article-title":"The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists","volume":"265","author":"Yi","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104553_b0045","article-title":"Annexins as potential targets in ocular diseases","volume":"27","author":"da Silva","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2025.104553_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/neuroglia6020019","article-title":"Electroretinographic and morphological characterization of the retina of Annexin A1 knockout mice","volume":"6","author":"da Silva","year":"2025","journal-title":"Neuroglia"},{"key":"10.1016\/j.drudis.2025.104553_b0055","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/bph.15919","article-title":"Formylpeptide receptor 2: nomenclature, structure, signalling and translational perspectives: IUPHAR review 35","volume":"179","author":"Qin","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.drudis.2025.104553_b0060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s43440-021-00271-x","article-title":"Formyl peptide receptor 2 as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology","volume":"73","author":"Tylek","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.drudis.2025.104553_b0065","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41467-022-28586-0","article-title":"Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2","volume":"13","author":"Zhuang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104553_b0070","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41467-020-14728-9","article-title":"Structure of formylpeptide receptor 2-Gi complex reveals insights into ligand recognition and signaling","volume":"11","author":"Zhuang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2025.104553_b0075","doi-asserted-by":"crossref","first-page":"15996","DOI":"10.3390\/ijms242115996","article-title":"Stimulation of the pro-resolving receptor Fpr2 reverses inflammatory microglial activity by suppressing NF\u03baB activity","volume":"24","author":"Wickstead","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101602","article-title":"Formyl peptide receptor 2 and heart disease","volume":"59","author":"Lupisella","year":"2022","journal-title":"Semin Immunol"},{"key":"10.1016\/j.drudis.2025.104553_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1568629","article-title":"The N-formyl peptide receptors: much more than chemoattractant receptors. Relevance in health and disease","volume":"16","author":"Napolitano","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104553_b0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.6.5.10","article-title":"Augmenting endogenous levels of retinal Annexin A1 suppresses uveitis in mice","volume":"6","author":"Gardner","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.drudis.2025.104553_b0095","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400656R","article-title":"LL37\/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy","volume":"38","author":"Lou","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2025.104553_b0100","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3389\/fimmu.2017.01852","article-title":"The G-protein-coupled chemoattractant receptor Fpr2 exacerbates high glucose-mediated proinflammatory responses of M\u00fcller glial cells","volume":"8","author":"Yu","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104553_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jop.2010.0187","article-title":"Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS","volume":"27","author":"He","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.drudis.2025.104553_b0110","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/cells10051049","article-title":"Anti-VEGF-resistant retinal diseases: a review of the latest treatment options","volume":"10","author":"Wallsh","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104553_b0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.64.5.28","article-title":"Mechanisms of acquired resistance to anti-VEGF therapy for neovascular eye diseases","volume":"64","author":"Sharma","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2024.1469966","article-title":"Infectious keratitis in Western New York: a 10-year review of patient demographics, clinical management, and treatment failure","volume":"4","author":"Maretz","year":"2024","journal-title":"Front Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.survophthal.2024.11.010","article-title":"Functional diabetic retinopathy: a new concept to improve management of diabetic retinal diseases","volume":"70","author":"Rai","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","article-title":"Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence","volume":"48","author":"Sim\u00f3","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.drudis.2025.104553_b0135","first-page":"535","article-title":"Anti-VEGF therapy for diabetic eye diseases","volume":"6","author":"Bahrami","year":"2017","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12886-024-03491-w","article-title":"Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice","volume":"24","author":"Moshfeghi","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300370","article-title":"Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human M\u00fcller cells","volume":"19","author":"Matsuda","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104553_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100161","article-title":"Do anti-VEGFs used in the ophthalmic clinic cause M\u00fcller glial cell stress?","volume":"78","author":"da Silva","year":"2023","journal-title":"Clinics"},{"key":"10.1016\/j.drudis.2025.104553_b0155","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1038\/s41598-019-47900-3","article-title":"Structure\u2013function relationship of an urokinase receptor-derived peptide which inhibits the formyl peptide receptor type 1 activity","volume":"9","author":"Minopoli","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104553_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185383","article-title":"A regulatory role for \u03b2-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina","volume":"12","author":"Shi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104553_b0165","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00417-021-05492-7","article-title":"Cellular components of the idiopathic epiretinal membrane","volume":"260","author":"da Silva","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0170","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1159\/000529578","article-title":"The G-protein-coupled formyl peptide receptor 2 promotes endothelial-mesenchymal transition in diabetic retinopathy","volume":"66","author":"Lou","year":"2023","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.drudis.2025.104553_b0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1096\/fba.2020-00034","article-title":"The G-protein-coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy","volume":"2","author":"Yu","year":"2020","journal-title":"FASEB Bioadv"},{"key":"10.1016\/j.drudis.2025.104553_b0180","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/ijms24021024","article-title":"The role of inflammation and therapeutic concepts in diabetic retinopathy\u2014a short review","volume":"24","author":"Gomu\u0142ka","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0185","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.18240\/ijo.2022.07.20","article-title":"Molecules related to diabetic retinopathy in the vitreous and involved pathways","volume":"15","author":"Xia","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0190","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.3389\/fimmu.2018.03076","article-title":"Hyperglycemia induces neutrophil extracellular traps formation through an NADPH oxidase-dependent pathway in diabetic retinopathy","volume":"9","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104553_b0195","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00297-17","article-title":"Modulation of neutrophil extracellular trap and reactive oxygen species release by periodontal bacteria","volume":"85","author":"Hirschfeld","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.drudis.2025.104553_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1202463","article-title":"Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.drudis.2025.104553_b0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000499541","article-title":"Diabetic retinopathy in the context of patients with diabetes","volume":"62","author":"Sim\u00f3-Servat","year":"2019","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.drudis.2025.104553_b0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1152\/jn.00224.2015","article-title":"Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes","volume":"114","author":"Shevalye","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.drudis.2025.104553_b0215","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/jcp.29303","article-title":"Resolvin D1 reduces mitochondrial damage to photoreceptors of primary retinal cells exposed to high glucose","volume":"235","author":"Trotta","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2025.104553_b0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fphar.2020.00235","article-title":"Resolvin D1 modulates the intracellular VEGF-related miRNAs of retinal photoreceptors challenged with high glucose","volume":"11","author":"Maisto","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104553_b0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.plefa.2009.10.010","article-title":"Neuroprotectin D1\/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils","volume":"82","author":"Marcheselli","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.drudis.2025.104553_b0230","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/eye.2014.226","article-title":"FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"28","author":"Liang","year":"2014","journal-title":"Eye"},{"key":"10.1016\/j.drudis.2025.104553_b0235","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.21037\/atm-21-3390","article-title":"LXA4 protects against blue-light induced retinal degeneration in human A2E-laden RPE cells and Balb\/c mice","volume":"9","author":"Xie","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.drudis.2025.104553_b0240","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.bbrc.2019.06.137","article-title":"Lipoxin A4 delays the progression of retinal degeneration via the inhibition of microglial overactivation","volume":"516","author":"Lu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2025.104553_b0250","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3390\/cells11213453","article-title":"A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration","volume":"11","author":"Heloter\u00e4","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104553_b0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.survophthal.2007.12.004","article-title":"Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment","volume":"53","author":"Soubrane","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0260","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10753-021-01555-3","article-title":"Crosstalk between RPE cells and choroidal endothelial cells via the ANXA1\/FPR2\/SHP2\/NLRP3 inflammasome\/pyroptosis axis promotes choroidal neovascularization","volume":"45","author":"Zhu","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.drudis.2025.104553_b0265","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1167\/iovs.15-18758","article-title":"The urokinase receptor-derived peptide UPARANT mitigates angiogenesis in a mouse model of laser-induced choroidal neovascularization","volume":"57","author":"Cammalleri","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0270","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00125-016-4204-0","article-title":"Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy","volume":"60","author":"Rezzola","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2025.104553_b0275","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.4049\/jimmunol.1202030","article-title":"Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2\u201326 in models of ocular inflammation in vivo and in vitro","volume":"190","author":"Girol","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.drudis.2025.104553_b0280","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1007\/s00417-022-05686-7","article-title":"Effect of resolvin D1 on experimental bacterial keratitis to prevent corneal scar","volume":"260","author":"Lee","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0285","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1111\/jcmm.15633","article-title":"Resolvin D1 attenuates the inflammatory process in mouse model of LPS-induced keratitis","volume":"24","author":"Petrillo","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.drudis.2025.104553_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108938","article-title":"The inhibiting effect of aspirin-triggered resolvin D1 in non-canonical pyroptosis in rats with acute keratitis","volume":"218","author":"Wang","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.drudis.2025.104553_b0295","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/09273948.2022.2070504","article-title":"Resolvin D1 inhibits corneal inflammation in Staphylococcus aureus keratitis","volume":"31","author":"Kim","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.drudis.2025.104553_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108941","article-title":"Resolvin D1 protects against Aspergillus fumigatus keratitis in diabetes by blocking the MAPK-NF-\u03baB pathway","volume":"216","author":"Qin","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.drudis.2025.104553_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107785","article-title":"Lipoxin A4 activates ALX\/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis","volume":"96","author":"Zhu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.drudis.2025.104553_b0310","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1189\/jlb.3HI1216-511RR","article-title":"Frontline science: aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology","volume":"102","author":"Rajasagi","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2025.104553_b0315","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejphar.2018.11.008","article-title":"Involvement of the annexin A1-Fpr anti-inflammatory system in the ocular allergy","volume":"842","author":"Marmorato","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.drudis.2025.104553_b0320","first-page":"187","article-title":"Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization","volume":"7","author":"Ren","year":"2014","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0325","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1167\/iovs.08-2462","article-title":"Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators","volume":"50","author":"Jin","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0330","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2353\/ajpath.2010.090678","article-title":"Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury","volume":"176","author":"Leedom","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.drudis.2025.104553_b0335","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1167\/iovs.14-14356","article-title":"The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation","volume":"55","author":"Hua","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0340","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/biom13050831","article-title":"Lipoxin A4 (LXA4) reduces alkali-induced corneal inflammation and neovascularization and upregulates a repair transcriptome","volume":"13","author":"He","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2025.104553_b0345","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1167\/iovs.05-1649","article-title":"Multifunctional roles of human cathelicidin (LL-37) at the ocular surface","volume":"47","author":"Huang","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0350","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2012.07.008","article-title":"Lipoxin A4 inhibits platelet-activating factor inflammatory response and stimulates corneal wound healing of injuries that compromise the stroma","volume":"103","author":"Kakazu","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.drudis.2025.104553_b0355","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1167\/iovs.10-6199","article-title":"EGF stimulates lipoxin A4 synthesis and modulates repair in corneal epithelial cells through ERK and p38 activation","volume":"52","author":"Kenchegowda","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2025.104553_b0360","first-page":"39","article-title":"Molecular mechanism of the inhibition effect of lipoxin A4 on corneal dissolving pathology process","volume":"6","author":"Zhou","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.drudis.2025.104553_b0365","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5905891","article-title":"Effect of treatment with salsalate, menhaden oil, combination of salsalate and menhaden oil, or resolvin D1 of C57Bl\/6J type 1 diabetic mouse on neuropathic endpoints","volume":"2016","author":"Yorek","year":"2016","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.drudis.2025.104553_b0370","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4172\/2155-9562.1000453","article-title":"Effect of fish oil vs. resolvin D1, E1, methyl esters of resolvins D1 or D2 on diabetic peripheral neuropathy","volume":"8","author":"Obrosov","year":"2017","journal-title":"J Neurol Neurophysiol"},{"key":"10.1016\/j.drudis.2025.104553_b0375","first-page":"274","article-title":"Resolvin D1 promotes corneal epithelial wound healing and restoration of mechanical sensation in diabetic mice","volume":"24","author":"Zhang","year":"2018","journal-title":"Mol Vis"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:15:07Z","timestamp":1780920907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1359644625002661"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104553","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FPR2 at the crossroads of inflammation and repair in the eye","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104553"}}